Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00227981
First received: September 26, 2005
Last updated: December 12, 2007
Last verified: December 2007

September 26, 2005
December 12, 2007
March 1995
Not Provided
Score on the Hamilton Rating Scale for Depression (measured at Month 24)
Score on the Hamilton Rating Scale for Depression; measured at baseline, Week 20, every 3 months, and Month 24
Complete list of historical versions of study NCT00227981 on ClinicalTrials.gov Archive Site
  • Score on the Beck Depression Inventory
  • Score on the Global Assessment of Functioning (measured at Month 24)
  • Score on the Beck Depression Inventory; measured at at baseline, Week 20, every 3 months, and Month 24
  • Score on the Global Assessment of Functioning; measured at baseline, Week 20, every 3 months, and Month 24
Not Provided
Not Provided
 
Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression
Maintenance Psychotherapies in Recurrent Depression: Study II

This study will evaluate the effectiveness of maintenance interpersonal psychotherapy (IPT) in preventing relapse of depression in women who have required combined psychotherapy and pharmacotherapy treatment to obtain a remission of depression symptoms.

Depression is a serious medical illness that can recur more than once in a person's lifetime. Effective treatment methods are needed to maintain a state of remission in people who have had prior episodes of depression. IPT is a brief and highly structured type of psychotherapy that addresses interpersonal issues associated with depression. Previous studies have shown that it is an effective method for treating depression. This study will evaluate the effectiveness of maintenance ITP in preventing relapse of depression in women who have required combined psychotherapy and pharmacotherapy treatment to obtain remission of depressive symptoms.

Participants in this open label study will be recruited from a previous study, "Maintenance Psychotherapy in Recurrent Depression: Study I." In this study participants will initially receive weekly sessions of IPT as well as medication treatment with fluoxetine. Any participants who do not reach remission of depressive symptoms after 6 weeks will be given other standard treatments for depression. Once remission of depressive symptoms is reached, participants will continue receiving weekly IPT and fluoxetine treatment for 20 weeks. After 20 weeks, fluoxetine treatment will be discontinued, and all participants will receive IPT alone for 6 weeks before entering the maintenance phase of the study. Upon entrance into this phase, participants will be randomly assigned to receive IPT weekly, biweekly, or monthly for 18 months. Functioning and depressive symptoms will be assessed at Month 24.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Depression
  • Behavioral: Interpersonal Psychotherapy
  • Drug: Fluoxetine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
93
March 2001
Not Provided

Inclusion Criteria:

  • Met all entry criteria for the parent study, "Maintenance Psychotherapy in Recurrent Depression, Study I"
  • Began IPT as outlined in the parent study
  • Demostrated compliance with IPT sessions during the parent study
  • Exhibits less than a 50% reduction in score on the Hamilton Rating Scale for Depression after 12 weeks of psychotherapy or fails to meet stabilization criteria after 24 weeks of psychotherapy during the parent study

Exclusion Criteria:

  • Any unstable medical illness
Female
20 Years to 60 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00227981
R01 MH49115, DSIR 950309-9905
Not Provided
Not Provided
National Institute of Mental Health (NIMH)
Not Provided
Principal Investigator: Ellen Frank, PhD University of Pittsburgh
National Institute of Mental Health (NIMH)
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP